Targeting neuroinflammation: 3-monothiopomalidomide a new drug candidate to mitigate traumatic brain injury and neurodegeneration
Shih‐Chang Hsueh(Taipei Medical University), Nigel H. Greig(National Institutes of Health)
Cited by 5
Related Papers
Mitophagy inhibits amyloid-β and tau pathology and reverses cognitive deficits in models of Alzheimer’s disease
|Nature Neuroscience|2019|1.7k
Posiphen as a candidate drug to lower CSF amyloid precursor protein, amyloid-β peptide and τ levels: target engagement, tolerability and pharmacokinetics in humans
|Journal of Neurology Neurosurgery & Psychiatry|2012|90
Brain and plasma pharmacokinetics and anticancer activities of cyclophosphamide and phosphoramide mustard in the rat
|Cancer Chemotherapy and Pharmacology|1990|50
Voluntary Physical Exercise Improves Subsequent Motor and Cognitive Impairments in a Rat Model of Parkinson’s Disease
|International Journal of Molecular Sciences|2018|50
Development of lipophilic anticancer agents for the treatment of brain tumors by the esterification of water-soluble chlorambucil
|Clinical & Experimental Metastasis|1993|34